Cabozantinib
Overview
Cabozantinib is a small molecule kinase inhibitor that targets multiple tyrosine kinases, including VEGFR2 and MET. It is primarily utilized in the treatment of medullary thyroid cancer and renal cell carcinoma.
API suppliers (4)
Suppliers of Cabozantinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- SICHUAN ELIXIR PHARMACEUTICAL CO LTD1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- CHANGZHOU PHARMACEUTICAL FACTORYChina1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
Therapeutic areas
Do you supply Cabozantinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.